Spots Global Cancer Trial Database for trc093 recombinant humanized igg1k monoclonal antibody
Every month we try and update this database with for trc093 recombinant humanized igg1k monoclonal antibody cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors | NCT00492830 | Cancer Neoplasm Metast... | TRC093 recombin... | 18 Years - | Tracon Pharmaceuticals Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
